Chiusa istruttoria per ottemperanza alla decisione di abuso di posizione dominante nei confronti di Leadiant, grazie all’azione dell’Autorità due società del gruppo hanno ridotto il prezzo di un farmaco

 AGCM, here.

Cinven (Luxo 1) S.a.r.l. and Others v Competition and Markets Authority

 CAT, here. 

La CNMC multa al laboratorio Leadiant con 10,25 millones por vender a un precio excesivo su medicamento huérfano para el tratamiento de una enfermedad rara.

 CNMC, aquì.

CMA accuses pharma firms of illegal pricing

 CMA, here. 

Commission accepts commitments by Aspen to reduce prices for six off-patent cancer medicines by 73% addressing excessive pricing concerns

 Here. 

Commission seeks feedback on commitments offered by Aspen to reduce prices for six off-patent cancer medicines by 73% to address Commission's concerns over excessive pricing

EC, here. 

Cape Town company agrees to pay R600,000 for over-charging for sanitisers

Times Live, here. 

Price regulation in times of crisis can be tricky

M. Motta, here. 

Data Services Market Inquiry: Final Report Presentation

South Africa Competition Commission, Video here.
Final Report's SUMMARY OF FINDINGS AND RECOMMENDATIONS, here. 

India antitrust probe finds Monsanto abused dominant position

Reuters, here. 

Intellectual Property and the Price of Prescription Drugs: Balancing Innovation and Competition

Senate Judiciary Committee, Hearing here. With the great Prof. Michael Carrier. 

Whistleblowers: Company at heart of 97,000% drug price hike bribed doctors to boost sales

CNN, here. 

HEARING ON “LOWERING THE COST OF PRESCRIPTION DRUGS: REDUCING BARRIERS TO MARKET COMPETITION”

Video, here. 

On Price Geysers

P. Marsden, Video here (from 50:25). Do watch it!












--------------------------------------------

And yes, this is the Jet d'Eau (59:58) - it'll always remind me of pills from now on - unsure it's a good thing...

...and this looks like the Lac Vert facing the Mont Blanc Chain (Mer de Glace on the left) (1:00:03) - nice, easy hike if you know the short cut to skip the crowd...

OECD Competition Open Day 2019

27 Feb. 2019, Live Webcast here: don't miss it! 

Infectious healthcare waste disposal sector in Corsica: excessive prices

Autorité de la concurrence, here. 

Excessive Prices in Pharmaceutical Markets

OECD, Background Note, here. 

ABUS D’EXPLOITATION : QUELS SONT LES NOUVEAUX RISQUES POUR LES ENTREPRISES ?

Concurrences, ici. 

Excessive Pricing And Sham Patent Litigation: The Pfizer And AbbVie Decisions

IP-Watch, here. 

Keine Verfahrenseinleitung gegen die Lufthansa wegen Preishöhenmissbrauchs

Bundeskartellamt, Fallbericht hier.